Respiratory Syncytial Virus

Disease State Hub

Research Summaries

Respiratory Diseases Roundup

Respiratory Diseases Roundup

Monoclonal Antibody Shows Promise Against RSV in Infants, Influenza Vaccine Updated, Metformin May Reduce Long COVID Risk, and More

11/05/2015

Miranda Manier, BA

In this respiratory disease roundup, researchers highlight the efficacy of clesrovimab in preventing respiratory syncytial virus infections in infants, the influenza vaccine's updated formulation this virus...

11/05/2015

Respiratory Syncytial Virus Snapshot

For more viral infections content, visit the Disease State Hub

Respiratory syncytial virus (RSV) is a common respiratory virus that typically causes mild symptoms, similar to a cold. Most people recover within 1 to 2 weeks, but it can be serious for infants and older adults.

For pulmonary disorders content, visit the Disease State Hub

Pulmonologists, Infectious Disease Specialists, Primary Care, Pediatricians, Geriatricians

People show symptoms within 4 to 6 days after infection, and symptoms typically appear in stages, rather than all at once.

Symptoms include: rhinorrhea (runny nose), decrease in appetite, coughing, sneezing, fever, and wheezing

For diagnosis strategies content, visit the Resource Center

Testing is not typically required, as the symptoms are similar to a cold. A physician may run tests, such as a mouth swab or blood test to check white blood cell count and the presence of viruses.

For public health content, visit the Resource Center

Globally, RSV affects 64 million people each year and causes 160,000 deaths annually. The virus is the most common cause of bronchiolitis (inflammation in the small airways of a person's lungs).

For critical care content, visit the Resource Center

RSV sends approximately 58,000 children aged 5 years or younger to hospitals for treatment every year. For the same population, 100 to 300 deaths can occur each year due to RSV. *United States data

For intensive care medicine content, visit the Resource Center

RSV in older adults results in 60,000 to 160,000 hospitalizations each year and approximately 6,000 to 10,000 adults aged 65 years or older die from the virus. *United States data

Research Summaries

Respiratory Diseases Roundup

Influenza Deaths Surpass COVID-19, Emerging Variants, and Viral Risks

03/03/2025

Miranda Manier, BA

This respiratory health update covers rising influenza deaths, the spread of new SARS-CoV-2 variants, shifting reinfection patterns, and cardiovascular risks in children

03/03/2025

Respiratory Diseases Roundup

Respiratory Diseases Roundup

Human Metapneumovirus Concerns, COVID-19 Impact on Kidney Health, Long COVID in Younger Adults, and More

02/04/2025

Miranda Manier, BA

In this respiratory disease roundup, experts examine the rising cases of human metapneumovirus in China, new research on COVID-19’s long-term effects on kidney function, the effectiveness of...

02/04/2025

Respiratory Diseases Roundup

Doctor putting a band-aid on an arm following a vaccine

Respiratory Diseases Roundup

Vaccine Hesitancy, Rising Avian Influenza Cases, Reducing the Risk of Multisystem Inflammatory Syndrome in Children, and More

01/13/2025

Miranda Manier, BA

In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...

01/13/2025

Respiratory Diseases Roundup

Nirmatrelvir-Ritonavir Lacks Benefit for Patients With Long COVID, CDC Updates Recommendations for “Triple Threat” Vaccines, and More

10/24/2024

Anthony Calabro, MA

In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...

10/24/2024

Research Summary

ACIP Releases 2024 Adult Immunization Schedule

03/26/2024

Jessica Ganga

The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...

03/26/2024

March 2025

Current Issue

March 2025

Volume 65

Issue 3

Sources: